These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11343371)

  • 1. Modelling survival data with a cured fraction using frailty models.
    Price DL; Manatunga AK
    Stat Med; 2001 May 15-30; 20(9-10):1515-27. PubMed ID: 11343371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A frailty mixture cure model with application to hospital admission data [corrected].
    Yu B
    Biom J; 2008 Jun; 50(3):386-94. PubMed ID: 18217699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for the presence of cured patients: a simulation study.
    Peng Y; Dear KB; Carriere KC
    Stat Med; 2001 Jun; 20(12):1783-96. PubMed ID: 11406841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new parametric model for survival data with long-term survivors.
    Shao Q; Zhou X
    Stat Med; 2004 Nov; 23(22):3525-43. PubMed ID: 15505885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Khadem Maboudi AA
    J Biopharm Stat; 2023 Jan; 33(1):90-113. PubMed ID: 35671330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distribution for multivariate frailty based on the compound Poisson distribution with random scale.
    Moger TA; Aalen OO
    Lifetime Data Anal; 2005 Mar; 11(1):41-59. PubMed ID: 15747589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint frailty model for recurrent events and death in presence of cure fraction: Application to breast cancer data.
    Talebi-Ghane E; Baghestani A; Zayeri F; Rondeau V; Akhavan A
    Biom J; 2021 Apr; 63(4):725-744. PubMed ID: 33368665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bivariate survival model with compound Poisson frailty.
    Wienke A; Ripatti S; Palmgren J; Yashin A
    Stat Med; 2010 Jan; 29(2):275-83. PubMed ID: 19856276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of clinical mastitis data using a nested frailty Cox model fit as a mixed-effects Poisson model.
    Elghafghuf A; Dufour S; Reyher K; Dohoo I; Stryhn H
    Prev Vet Med; 2014 Dec; 117(3-4):456-68. PubMed ID: 25449735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of testicular cancer data using a frailty model with familial dependence.
    Moger TA; Aalen OO; Heimdal K; Gjessing HK
    Stat Med; 2004 Feb; 23(4):617-32. PubMed ID: 14755393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case Study Examining the Usefulness of Cure Modelling for the Prediction of Survival Based on Data Maturity.
    Grant TS; Burns D; Kiff C; Lee D
    Pharmacoeconomics; 2020 Apr; 38(4):385-395. PubMed ID: 31848900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of a Mixture Cure Rate Model based on the Generalized Modified Weibull Distribution for the Analysis of Leukemia Patients.
    Omer ME; Abu Bakar M; Adam M; Mustafa M
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1045-1053. PubMed ID: 33906295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cure frailty models for survival data: application to recurrences for breast cancer and to hospital readmissions for colorectal cancer.
    Rondeau V; Schaffner E; Corbière F; Gonzalez JR; Mathoulin-Pélissier S
    Stat Methods Med Res; 2013 Jun; 22(3):243-60. PubMed ID: 21632696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportional hazards under Conway-Maxwell-Poisson cure rate model and associated inference.
    Balakrishnan N; Barui S; Milienos FS
    Stat Methods Med Res; 2017 Oct; 26(5):2055-2077. PubMed ID: 28523958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.